Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal‐Transplant Patients
@article{Zhao2010PopulationPA, title={Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal‐Transplant Patients}, author={W. Zhao and M. Fakhoury and G. Desch{\^e}nes and G. Roussey and K. Brochard and P. Niaudet and M. Tsimaratos and J. Andr{\'e} and S. Cloarec and P. Cochat and A. Bensman and S. Azougagh and E. Jacqz-Aigrain}, journal={The Journal of Clinical Pharmacology}, year={2010}, volume={50} }
The objective was to develop a population pharmacokinetic‐pharmacogenetic model of mycophenolic acid following administration of mycophenolate mofetil (MMF) in de novo pediatric renal‐transplant patients and identify factors that explain variability. The pharmacokinetic samples were collected from 89 de novo pediatric renal‐transplant patients treated with MMF and studied during the first 60 postoperative days. All patients were genotyped for UGT1A8–A9, UGT2B7, and ABCC2. Population… Expand
Topics from this paper
51 Citations
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients
- Medicine
- European Journal of Clinical Pharmacology
- 2012
- 52
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.
- Medicine
- Pharmacological research
- 2011
- 26
- PDF
Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
- Medicine
- British journal of clinical pharmacology
- 2014
- 9
Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach
- Medicine
- Renal failure
- 2015
- 11
Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients’ and donors’ ABCC2 gene variants, and their interactions
- Medicine
- European Journal of Clinical Pharmacology
- 2017
- 4
UGT1A9, UGT2B7, and MRP2 Genotypes Can Predict Mycophenolic Acid Pharmacokinetic Variability in Pediatric Kidney Transplant Recipients
- Biology, Medicine
- Therapeutic drug monitoring
- 2012
- 41
Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients
- Medicine
- Clinical Pharmacokinetics
- 2012
- 55
Population pharmacokinetics of mycophenolic acid in paediatric patients
- Medicine
- British journal of clinical pharmacology
- 2020
Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease
- Medicine
- Clinical Pharmacokinetics
- 2013
- 39
- Highly Influenced
References
SHOWING 1-10 OF 60 REFERENCES
Population Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Pediatric and Adolescent Patients
- Medicine
- Therapeutic drug monitoring
- 2005
- 51
Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients
- Medicine
- Clinical pharmacokinetics
- 2005
- 98
Validation of an Abbreviated Pharmacokinetic Profile for the Estimation of Mycophenolic Acid Exposure in Pediatric Renal Transplant Recipients*
- Medicine
- Therapeutic drug monitoring
- 2006
- 51
Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients
- Medicine
- Clinical pharmacokinetics
- 2006
- 58
AcylMPAG Plasma Concentrations and Mycophenolic Acid-Related Side Effects in Patients Undergoing Renal Transplantation Are Not Related to the UGT2B7-840G>A Gene Polymorphism
- Biology, Medicine
- Therapeutic drug monitoring
- 2008
- 44
Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid
- Chemistry, Medicine
- Therapeutic drug monitoring
- 2001
- 295
Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Concentrations in Stable Renal Transplant Patients
- Medicine
- Clinical pharmacokinetics
- 2004
- 108
UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients
- Medicine
- Clinical pharmacology and therapeutics
- 2009
- 36
Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting Periods
- Medicine
- Therapeutic drug monitoring
- 2005
- 88
Time-dependent clearance of mycophenolic acid in renal transplant recipients.
- Medicine
- British journal of clinical pharmacology
- 2007
- 57
- Highly Influential